Mounjaro vs Ozempic — Which One Works Better? - The SURMOUNT-5 Verdict

Dr. Ben Synth unpacks the SURMOUNT-5 trial, the first head-to-head comparison of tirzepatide and semaglutide for weight loss. Tirzepatide produced 47% more weight loss—20.2% versus 13.7%—in this 72-week study of 751 adults without diabetes. He examines trial design, secondary endpoints, limitations, and what these results mean for patients choosing between the most talked-about drugs in modern medicine. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.